CONTACT US
Contact the team at MSWA if you have any related questions.
18 October 2022
On 14 October 2022, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended that Evusheld not be listed on the Pharmaceutical Benefits Scheme (PBS). However, this may be revised in the future and access will remain through current schemes.
For more information on this announcement click here | For information about Evusheld click here